Economy
Novartis (NOVN.S.), based in Switzerland, announced on Tuesday that it is increasing its profit prediction for the entire year for the third time. The...
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Hi, what are you looking for?
Novartis (NOVN.S.), based in Switzerland, announced on Tuesday that it is increasing its profit prediction for the entire year for the third time. The...
Novartis (NOVN.S) will buy Seattle company Chinook Therapeutics (KDNY.O) for up to $3.5 billion to add a rare severe kidney disease treatment to its...
Sandoz, the generics branch of Novartis (NOVN.S), will be spun off soon, and the Swiss company said Thursday that it expects the new company...
Novartis (NOVN.S) announced the new Sandoz board members on Monday. The Basel corporation accepted Sandoz Chairman-designate Gilbert Ghostine’s ten board members, who will begin...
After a breast cancer medication trial success and the development of a prostate cancer radiation medicine, Novartis (NOVN.S) boosted its full-year profits estimate, citing...
Google announced Tuesday, July 15, that they will develop and produce contact lenses that could potentially measure wearers’ blood sugar levels. The Huffington Post...